Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria M Villaflor

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Journal for Immunotherapy of Cancer|August 25, 2025
Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinomaRobert L Ferris, Rom S Leidner, Christine H Chung, et al.
Oncotarget|March 3, 2016
Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigationJanani Vigneswaran, Yi-Hung Carol Tan, Septimiu D Murgu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2014
Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancerEzra E W Cohen, Theodore G Karrison, Masha Kocherginsky, et al.
Cancer Research|October 27, 2012
Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancersRifat Hasina, Nathan Mollberg, Ichiro Kawada, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Journal for Immunotherapy of Cancer|August 25, 2025
Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinomaRobert L Ferris, Rom S Leidner, Christine H Chung, et al.
Oncotarget|March 3, 2016
Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigationJanani Vigneswaran, Yi-Hung Carol Tan, Septimiu D Murgu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2014
Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancerEzra E W Cohen, Theodore G Karrison, Masha Kocherginsky, et al.
Cancer Research|October 27, 2012
Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancersRifat Hasina, Nathan Mollberg, Ichiro Kawada, et al.
Pageof 5